1-5 of 5
Mary Jane Staab
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-Time Immune Monitoring to Guide Plasmid DNA Vaccination Schedule Targeting Prostatic Acid Phosphatase in Patients with Castration-Resistant Prostate Cancer

Free
Douglas G. McNeel, Jordan T. Becker, Jens C. Eickhoff, Laura E. Johnson, Eric Bradley, Isabel Pohlkamp, Mary Jane Staab, Glenn Liu, George Wilding, Brian M. Olson
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (14): 3692–3704.
https://doi.org/10.1158/1078-0432.CCR-14-0169
Published: 14 July 2014
View articletitled, Real-Time Immune Monitoring to Guide Plasmid DNA Vaccination Schedule Targeting Prostatic Acid Phosphatase in Patients with Castration-Resistant Prostate Cancer
Open the PDF for Real-Time Immune Monitoring to Guide Plasmid DNA Vaccination Schedule Targeting Prostatic Acid Phosphatase in Patients with Castration-Resistant Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Randomized, Double-Blinded Phase II Evaluation of Docetaxel with or without Doxercalciferol in Patients with Metastatic, Androgen-Independent Prostate Cancer

Free
Steven Attia, Jens Eickhoff, George Wilding, Douglas McNeel, Jules Blank, Harish Ahuja, Alcee Jumonville, Michael Eastman, Daniel Shevrin, Michael Glode, Dona Alberti, Mary Jane Staab, Dottie Horvath, Jane Straus, Rebecca Marnocha, Glenn Liu
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (8): 2437–2443.
https://doi.org/10.1158/1078-0432.CCR-07-4274
Published: 15 April 2008
View articletitled, Randomized, Double-Blinded Phase II Evaluation of Docetaxel with or without Doxercalciferol in Patients with Metastatic, Androgen-Independent Prostate Cancer
Open the PDF for Randomized, Double-Blinded Phase II Evaluation of Docetaxel with or without Doxercalciferol in Patients with Metastatic, Androgen-Independent Prostate Cancer in another window
Journal Articles

A Phase II Multicenter, Randomized, Double-Blind, Safety Trial Assessing the Pharmacokinetics, Pharmacodynamics, and Efficacy of Oral 2-Methoxyestradiol Capsules in Hormone-Refractory Prostate Cancer

Free
Christopher Sweeney, Glenn Liu, Constantin Yiannoutsos, Jill Kolesar, Dorothea Horvath, Mary Jane Staab, Karen Fife, Victoria Armstrong, Anthony Treston, Carolyn Sidor, George Wilding
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (18): 6625–6633.
https://doi.org/10.1158/1078-0432.CCR-05-0440
Published: 15 September 2005
View articletitled, A Phase II Multicenter, Randomized, Double-Blind, Safety Trial Assessing the Pharmacokinetics, Pharmacodynamics, and Efficacy of Oral 2-Methoxyestradiol Capsules in Hormone-Refractory Prostate Cancer
Open the PDF for A Phase II Multicenter, Randomized, Double-Blind, Safety Trial Assessing the Pharmacokinetics, Pharmacodynamics, and Efficacy of Oral 2-Methoxyestradiol Capsules in Hormone-Refractory Prostate Cancer in another window
Journal Articles

Phase II Study of 1α-Hydroxyvitamin D2 in the Treatment of Advanced Androgen-independent Prostate Cancer

Free
Glenn Liu, George Wilding, Mary Jane Staab, Dorthea Horvath, Kelly Miller, Amy Dresen, Dona Alberti, Rhoda Arzoomanian, Rick Chappell, Howard H. Bailey
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (11): 4077–4083.
Published: 30 September 2003
View articletitled, Phase II Study of 1α-Hydroxyvitamin D2 in the Treatment of Advanced Androgen-independent Prostate Cancer
Open the PDF for Phase II Study of 1α-Hydroxyvitamin D2 in the Treatment of Advanced Androgen-independent Prostate Cancer in another window
Journal Articles

Phase I Trial of 1α-Hydroxyvitamin D2 in Patients with Hormone Refractory Prostate Cancer

Free
Glenn Liu, Kurt Oettel, Gregory Ripple, Mary Jane Staab, Dorothea Horvath, Dona Alberti, Rhoda Arzoomanian, Rebecca Marnocha, Reginald Bruskewitz, Richard Mazess, Charles Bishop, Abhik Bhattacharya, Howard Bailey, George Wilding
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (9): 2820–2827.
Published: 01 September 2002
View articletitled, Phase I Trial of 1α-Hydroxyvitamin D2 in Patients with Hormone Refractory Prostate Cancer
Open the PDF for Phase I Trial of 1α-Hydroxyvitamin D2 in Patients with Hormone Refractory Prostate Cancer in another window